Evidence map›Paper›PMID 30054900›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2019

HPV Vaccination Communication Messages, Messengers, and Messaging Strategies.

Kathleen B Cartmell, Carlie R Mzik, Beth L Sundstrom, John S Luque, Ashley White, Jennifer Young-Pierce

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Human Papillomavirus: A Narrative Review for Dental Providers in Prevention and Care.International journal of environmental research and public health · 2025
    Review
  17. Review
  18. Exploring Trusted Sources of HPV Vaccine Information Among Mexican American Parents in El Paso, Texas.International journal of environmental research and public health · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kathleen B CartmellMedical University of South Carolina, College of Nursing, 99 Jonathan Lucas Street, Charleston, SC, 29425, USA. cartmelk@musc.edu.
Carlie R MzikMedical University of South Carolina, College of Nursing, 99 Jonathan Lucas Street, Charleston, SC, 29425, USA.
Beth L SundstromCollege of Charleston, Charleston, SC, USA.
John S LuqueInstitute of Public Health, Florida A&M University, Tallahassee, FL, USA.
Ashley WhiteDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Jennifer Young-PierceUniversity of South Alabama Mitchell Cancer Institute, Mobile, AL, USA.
Medical University of South Carolina · USCollege of Charleston · USFlorida Agricultural and Mechanical University · USUniversity of South Alabama · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
South Carolina Cancer Disparities Research Center (SC CADRE)U54CA210962 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CARROLL, STEVEN L. · 2017 to 2023
$6.7M
South Carolina Cancer Disparities Research Center (SC CaDRe)U54CA210963 · NCI · SOUTH CAROLINA STATE UNIVERSITY · PI WARSHAMANA-GREENE, GNANA SAKUNTALA · 2017 to 2023
$6.1M
NCI NIH HHS #3P30CA138313-06S2NCI NIH HHS P30 CA138313NCI NIH HHS U54 CA210962NCI NIH HHS U54 CA210963
6 · The paper itself

Abstract

Human papillomavirus (HPV) causes over 39,000 cancers annually in the US. The HPV vaccine is safe and effective but underutilized to prevent cancer. In the US, only 37% of adolescents ages 13-17 have received the full vaccine series. Ineffective messages and misinformation about the vaccine have negatively impacted its uptake in the US. It was initially only approved for girls and early marketing focused on cervical cancer prevention and prevention of HPV as a sexually transmitted infection. Understanding effective messages and methods of dissemination is critical to address suboptimal vaccine uptake. Qualitative interviews were conducted with 34 participants to identify best practices for HPV vaccination messaging in SC. Participants included state leaders representing public health, medical associations, K-12 public schools, universities, insurers, and cancer advocacy organizations. Recommended HPV vaccine messages included focusing on cancer prevention rather than sexual transmission, routinizing the vaccine, and highlighting risks/costs of HPV. Targeting messages to specific demographics and utilizing multiple media platforms to disseminate consistent, scientifically accurate messages were recommended. Strategies such as appealing to parents' moral responsibility to protect their children against cancer and addressing the ubiquity of HPV and sharing growing evidence that HPV may be transmitted independent of sexual activity were also recommended. Suggested HPV vaccine messengers included trusted peers, medical professionals, and health associations. Culture-centered narratives to raise the voices of cancer survivors and parents were also recommended. This study provides an array of HPV vaccination messages and dissemination strategies for optimizing HPV vaccination rates.

Indexed as

Health CommunicationHealth Knowledge, Attitudes, PracticePatient Acceptance of Health CareAdolescentAdultChildFemaleHumansMaleMiddle AgedMotivationNarrationPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesParentsPapillomavirus VaccinesCommunicationEnvironmental scanEvaluationHPV-related cancersHPV vaccinationImplementation

Identifiers

PMID30054900
PMCPMC9673969
OpenAlexW2884672934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.